4.6 Article

Targeted delivery of vitamin D to the colon using β-glucuronides of vitamin D: therapeutic effects in a murine model of inflammatory bowel disease

出版社

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpgi.00156.2011

关键词

1,25-dihydroxyvitamin D-3; 1,25-dihydroxyvitamin D-3-25-beta-glucuronide; 24-hydroxylase; dextran sodium sulfate

资金

  1. Grow Iowa Values Fund

向作者/读者索取更多资源

Goff JP, Koszewski NJ, Haynes JS, Horst RL. Targeted delivery of vitamin D to the colon using beta-glucuronides of vitamin D: therapeutic effects in a murine model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 302: G460-G469, 2012. First published November 23, 2011; doi:10.1152/ajpgi.00156.2011.-1,25-Dihydroxyvitamin D-3 [1,25(OH)(2)D] has been shown to inhibit development of dextran sodium sulfate (DSS)-induced colitis in mice but can also cause hypercalcemia. The aim of this study was to evaluate whether beta-glucuronides of vitamin D could deliver 1,25(OH)(2)D to the colon to ameliorate colitis while reducing the risk of hypercalcemia. Initial studies demonstrated that bacteria residing in the lower intestinal tract were capable of liberating 1,25(OH)(2)D from 1,25-dihydroxyvitamin D-3-25-beta-glucuronide [beta-gluc-1,25(OH)(2)D]. We also determined that a much greater upregulation of the vitamin D-dependent 24-hydroxylase gene (Cyp24) was induced in the colon by treatment of mice with an oral dose of beta-gluc-1,25(OH)(2)D than 1,25(OH) 2D, demonstrating targeted delivery of 1,25(OH)(2)D to the colon. We then tested beta-glucuronides of vitamin D in the mouse DSS colitis model in two studies. In mice receiving DSS dissolved in distilled water and treated with 1,25(OH)(2)D or beta-gluc-1,25(OH)(2)D, severity of colitis was reduced. Combination of beta-gluc-1,25(OH)(2)D with 25-hydroxyvitamin D-3-25-beta-glucuronide [beta-gluc-25(OH)D] resulted in the greatest reduction of colitis lesions and symptoms in DSS-treated mice. Plasma calcium concentrations were lower in mice treated with beta-gluc-1,25(OH)(2)D alone or in combination with beta-gluc25(OH)D than in mice treated with 1,25(OH)(2)D, which were hypercalcemic at the time of death. beta-Glucuronides of vitamin D compounds can deliver 1,25(OH)(2)D to the lower intestine and can reduce symptoms and lesions of acute colitis in this model.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据